# CNO Financial Group account plan

> CNO Financial Group is a US insurer for middle-income retirees (Bankers Life, Washington National, Colonial Penn) with $4.5 billion of 2025 revenues.

## At a glance

CNO Financial Group is a holding company, headquartered in Carmel, Indiana, for insurers that develop, market and administer health insurance, annuities and individual life insurance for middle-income pre-retiree and retired Americans. It sells under the Bankers Life, Washington National and Colonial Penn brands through a Consumer Division (about 4,600 producing exclusive agents plus a large direct-to-consumer business) and a Worksite Division. In 2025 it had revenues of $4.5 billion, net income of $229.3 million, net operating income of $439.2 million and about 3,300 full-time associates, with total assets of $38.8 billion. Gary C. Bhojwani has been CEO since January 2018.

## Business units

- **Annuities** (42 percent of 2025 premium collections ($1,943.3 million)): Mainly fixed indexed annuities ($1,739.9 million of collections, up 12.8 percent) plus fixed interest annuities, sold only through captive distribution to middle-income savers. Annuity margin was $238.6 million in 2025; annuity collected premiums were $514 million in Q3 2026, up 9%.
- **Health**: Supplemental health (16 percent of 2025 collections), Medicare supplement (14 percent) and short-duration long-term care (6 percent), producing the largest margin, $556.6 million in 2025. Medicare Supplement NAP rose 41% in Q3 2026 as consumers shift away from Medicare Advantage.
- **Life** (21 percent of 2025 premium collections ($984.5 million)): Traditional life (whole, graded benefit and term) and interest-sensitive universal life, with a 2025 margin of $272.4 million. Marketing is moving from television to web, digital and third-party channels.
- **Consumer Division**: Serves individuals by phone, online and face to face through about 4,600 producing exclusive agents in about 230 branch and satellite offices plus one of the largest direct-to-consumer insurance businesses. Led by Scott L. Goldberg; career field agent NAP rose 13% in Q3 2026.
- **Worksite Division**: Sells voluntary supplemental health and life insurance to employers, associations and membership groups through about 400 exclusive producing agents. Led by Karen J. DeToro; NAP rose 18% in Q3 2026, the eighth consecutive quarter of double-digit growth, after the exit from Worksite fee services (Optavise).

## Strategic priorities

- **Top-quartile ROE**: The target of a 200 basis point run-rate operating ROE improvement through 2027 is expected to be exceeded in 2026; the next goal is "to become a consistent top quartile player", with new targets due February 2027.
- **Captive agent distribution**: Grow the exclusive agent force: 15th consecutive quarter of producing agent count growth in Q3 2026, with the career agency generating about 90% of Worksite insurance sales.
- **Capture the Medicare Advantage to Medicare Supplement shift**: More than 3 million Medicare Advantage members must choose new coverage for 2027; Medicare is used as a door-opening product, with annuities deepening the relationship.
- **TechMod technology modernization**: A three-year project started in 2025 to migrate to modernized insurance administrative platforms, with about $70 million of spend expected in 2026 and a comparable amount in 2027.
- **Shift marketing off television**: Non-television channels generated 71% of direct-to-consumer life sales in Q3 2026 as advertising moves to web, digital and third-party channels.
- **Focus on core insurance**: Exit of the Worksite fee services business, substantially complete as of June 30, 2026, to sharpen focus on the core insurance business.

## Latest results

In Q3 2026 net operating income rose to $179.1 million from $127.2 million, or $134.2 million versus $95.0 million excluding significant items, and operating EPS rose 47%. Total net investment income rose 13 percent to $350.7 million, and the annual actuarial review added $56.3 million to insurance product margins. Medicare supplement margins were hit by higher morbidity, while long-term care and traditional life margins grew. Full-year 2026 operating EPS guidance was raised to $5.05 to $5.15 (previously $4.60 to $4.80), with an expense ratio of 18.6 to 18.8 percent and free cash flow of $220 to $240 million.

## Investments and deals

- **TechMod**: $20.3 million of expense in 2025 and $33.5 million of non-operating expense in the first nine months of 2026, mainly data conversion and migration to modernized administrative platforms.
- **CNO Bermuda Re**: Reinsured $1.9 billion of supplemental health reserves from October 1, 2025 and about $270 million of Colonial Penn graded benefit life reserves from October 1, 2026; the planned in-force transactions are essentially complete.
- **Optavise exit**: Exit from Worksite fee services announced November 2025, with a $101.9 million goodwill and other asset impairment.
- **Share buybacks**: $319.9 million of buybacks in 2025 and $180.0 million in the first nine months of 2026.

## Challenges and risks

- **Medicare supplement morbidity**: Higher Q3 2026 morbidity hit Medicare supplement margins, with the adjusted margin at 17 percent versus 19 percent; a 10 percent increase in assumed morbidity would cut pre-tax income by $68 million.
- **Falling Medicare Advantage fee income**: Medicare Advantage sales fell 17.6 percent in nine months of 2026 and fee income guidance was cut to about $25 million.
- **Agent recruiting and retention**: The model depends on attracting and retaining agents and marketing organizations, against larger, higher-rated insurers and direct marketers.
- **Interest rates and investment risk**: Rates and credit conditions affect the $30.0 billion portfolio and annuity spreads; about $3.9 billion of liabilities could be surrendered without penalty.
- **Cyber and AI operational risk**: The 10-K lists cyber and IT interruption, AI-related operational risk and outsourcing among its risks.

## What leadership says

> "Our exclusive middle market focus and our last-mile captive agent distribution model are the foundation of our durable competitive moat." — Gary Bhojwani, Chief Executive Officer, Q3 2026 earnings call, 30 October 2026

> "There is a secular shift happening from Medicare Advantage to Medicare Supplement" — Gary Bhojwani, Chief Executive Officer, Q3 2026 earnings call, 30 October 2026

> "As often as anything, our competition is a bank CD." — Gary Bhojwani, Chief Executive Officer, Q2 2026 earnings call, 31 July 2026

> "12% return on equity was not the destination but rather a waypoint" — Paul McDonough, Chief Financial Officer, Q2 2026 earnings call, 31 July 2026


## Where a supplier can help

- **Core platform migration and data conversion**: Tied to TechMod: data conversion, platform migration and consulting are the named cost lines of a programme spending about $70 million in 2026.
- **Agent recruiting and productivity tools**: Tied to the captive agent distribution priority and the recruiting challenge: tools for recruiting, onboarding and equipping exclusive agents.
- **Digital marketing and lead generation**: Tied to the shift off television: web, digital and third-party channels now drive most direct-to-consumer life sales.
- **Medicare advice at scale**: Tied to the Medicare Advantage to Medicare Supplement shift: call-centre, quoting and enrolment tools for the 2027 coverage switch.
- **Claims and morbidity analytics**: Tied to the Medicare supplement morbidity challenge: claims analytics and pricing tools to protect health margins.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [CNO Financial Group Annual Report on Form 10-K for fiscal year 2025](https://www.sec.gov/Archives/edgar/data/1224608/000122460826000017/cno-20251231.htm)

Annual report · 2026-02-24

- CNO Financial Group is a US holding company (Carmel, Indiana) for insurers that develop, market and administer health insurance, annuities and individual life insurance, focused on "middle-income pre-retiree and retired Americans"; brands Bankers Life, Washington National and Colonial Penn.
- FY2025: revenues of $4.5 billion, net income of $229.3 million ($2.30 per diluted share), net operating income of $439.2 million ($4.40 per diluted share, up from $3.97); total assets $38.8 billion; about 3,300 full-time associates.
- Premium collections of $4.6 billion: annuities $1,943.3 million (42%), life $984.5 million (21%), supplemental health $744.5 million (16%), Medicare supplement $626.8 million (14%), long-term care $292.2 million (6%).
- Sold through two divisions: Consumer (about 4,600 producing exclusive agents in about 230 branch and satellite offices, plus one of the largest direct-to-consumer insurance businesses) and Worksite (about 400 exclusive producing agents selling voluntary benefits to employers).
- Total insurance product margin $1,067.6 million: health $556.6 million, life $272.4 million, annuity $238.6 million; expense ratio improved to 18.9 percent from 19.2 percent.
- Strategic moves: exit of the Worksite fee services business (Optavise) announced November 2025, with a $101.9 million goodwill and other asset impairment; TechMod, a three-year technology modernization started in 2025 ($20.3 million of expense in 2025); CNO Bermuda Re reinsured $1.9 billion of supplemental health reserves from October 1, 2025.
- Target: improve run-rate operating ROE by 200 basis points through 2027 from a 2024 run-rate of about 10 percent; operating ROE excluding significant items was 11.4 percent in 2025.
- Medicare supplement sales were very strong in Q4 2025, reflecting a shift in consumer preference from Medicare Advantage to Medicare Supplement, "reversing a decade-long trend".
- Capital: RBC ratio 380 percent (target 360-390 percent), holding company free cash flow $365.5 million, $319.9 million of share buybacks (8.1 million shares) and $66.4 million of dividends.
- Key risks: interest rates and investment portfolio, adequacy of premium rates and reserves (Medicare supplement morbidity), dependence on agent recruiting and retention, ratings below many competitors, NOL preservation, cyber and AI-related operational risk.

### [CNO Financial Group Quarterly Report on Form 10-Q for Q3 2026](https://www.sec.gov/Archives/edgar/data/1224608/000122460826000074/cno-20260930.htm)

Interim report · 2026-11-05

- Q3 2026 net operating income $179.1 million versus $127.2 million in Q3 2025; nine-month net operating income $399.9 million versus $295.8 million; excluding significant items $134.2 million in the quarter versus $95.0 million.
- The Q3 2026 comprehensive annual actuarial review added $56.3 million to insurance product margins and $36.0 million to net income.
- Insurance product margin $333.0 million ($276.7 million excluding significant items, versus $259.2 million); total net investment income up 13 percent to $350.7 million.
- Guidance raised: 2026 operating EPS of $5.05 to $5.15 (previously $4.60 to $4.80), expense ratio 18.6 to 18.8 percent, fee income about $25 million, free cash flow $220 to $240 million.
- 2026 operating ROE expected to exceed the 12 percent target set for year-end 2027; operating ROE excluding significant items was 14.1 percent; new targets due February 2027.
- CNO Bermuda Re's third treaty reinsured about $270 million of graded benefit life reserves from Colonial Penn, effective October 1, 2026.
- Medicare Advantage sales fell 7.9 percent in the quarter and 17.6 percent in nine months on the continued shift toward Medicare supplement; Medicare supplement margin hit by higher Q3 morbidity.
- TechMod: $33.5 million of non-operating expense in nine months; about $70 million of spend expected in 2026.
- Capital: RBC ratio 374 percent; 3.8 million shares bought back for $180.0 million in nine months; $22.1 million valuation allowance on capital loss carryforwards.

### [CNO Financial Group Q3 2026 Earnings Call Transcript](https://www.fool.com/earnings/call-transcripts/2026/10/30/cno-financial-cno-q3-2026-earnings-call-transcript/)

Executive talk · Gary Bhojwani, Chief Executive Officer · 2026-10-30

- CEO Gary Bhojwani: operating EPS up 47% in Q3 2026 and 43% year to date; 17th consecutive quarter of sales growth and 15th of producing agent count growth; full-year operating EPS guidance raised to $5.05-$5.15, up 9% at the midpoint.
- The moat: "Our exclusive middle market focus and our last-mile captive agent distribution model are the foundation of our durable competitive moat."
- Medicare: Medicare Supplement NAP up 41% in the quarter and more than 60% over 12 months; more than 3 million Medicare Advantage members must choose new coverage for 2027, which plays to CNO's advice-based model.
- Consumer: career field agent NAP up 13%, health NAP up 7%, life NAP down 9% against a prior-year $13 million third-party pilot (up 20% excluding it); annuity collected premiums $514 million, up 9%; client assets nearly $20 billion.
- Worksite: NAP up 18%, eighth consecutive quarter of double-digit growth; NAP from new clients up 168%; life sales up 59%.
- CFO Paul McDonough: expense ratio 18.5% on a trailing 12-month basis; operating ROE 14.1% excluding significant items; new money rate 6.24%, the 15th consecutive quarter above 6%.
- Bermuda: third treaty ceded about $270 million of Colonial Penn graded benefit life reserves; the planned in-force transactions are essentially complete, with 2027 focused on optimizing assets and capital there.
- TechMod cash spend of roughly $70 million in 2026 and a comparable amount expected in 2027.
- Bhojwani's goal: "to become a consistent top quartile player" on ROE; new long-term targets in February 2027.

### [CNO Financial Group Q2 2026 Earnings Call Transcript](https://www.webull.com/news/15364698024322048)

Executive talk · Gary Bhojwani, Chief Executive Officer · 2026-07-31

- CEO Gary Bhojwani: operating EPS up 45% in Q2 2026 and 43% year to date excluding significant items; 16th consecutive quarter of sales growth; total NAP up 7% with multiple sales records.
- CFO Paul McDonough: operating EPS $1.26; expense ratio 18.4%; trailing operating ROE 14.1%, 13.1% excluding significant items; full-year operating EPS guidance raised to $4.60-$4.80, up 8% at the midpoint.
- Medicare Supplement NAP up 52%, third consecutive quarter above 50%, driven by the shift away from Medicare Advantage; more than 11 thousand Americans turn 65 each day.
- Consumer: health NAP up 17%, life NAP down 9% on lower direct-to-consumer sales; record annuity collected premiums of $536 million; non-TV channels produced nearly 72% of D2C life sales.
- Worksite: record NAP up 29%; life up 44%; NAP from new clients up 84%; the career agency generates about 90% of Worksite insurance sales.
- 2026 operating ROE expected to exceed the 12% target set for year-end 2027; "12% return on equity was not the destination but rather a waypoint".
- Capital deployment unchanged: TechMod reinvestment, selective inorganic growth, dividends and buybacks; Bhojwani still thinks the company "is undervalued".
- Annuity competition: captive distribution and middle-income focus mean "As often as anything, our competition is a bank CD".

## Questions about CNO Financial Group

### What does CNO Financial Group do?

CNO's insurers sell health insurance, annuities and life insurance to middle-income pre-retiree and retired Americans under the Bankers Life, Washington National and Colonial Penn brands.

### What was CNO's revenue in 2025?

Revenues were $4.5 billion in 2025, with net income of $229.3 million and net operating income of $439.2 million.

### How many employees does CNO have?

About 3,300 full-time associates, nearly all in the United States, plus about 4,600 producing exclusive agents in the Consumer Division.

### Who leads CNO Financial Group?

Gary C. Bhojwani has been CEO since January 2018 and Paul H. McDonough has been CFO since March 2019.

### What is CNO's 2026 guidance?

Operating EPS of $5.05 to $5.15 excluding significant items, an expense ratio of 18.6 to 18.8 percent and free cash flow of $220 to $240 million.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
